English | Español

Celgene Corporation
Karen Kidd | Oct 23, 2018

Think tank founder recommends standard patents over intellectual property rights to cut drug prices
Carrice Quinnie | Jun 2, 2017

Celgene sees positive results in trial of oral ozanimod for relapsing multiple sclerosis
LocalLabs News Service | Apr 10, 2017

Oral medication reduced psoriasis symptoms, study says
Gene Johnson | Mar 10, 2017

FDA accepts Celgene Corp.'s application for leukemia treatment drug
Amanda Rupp | Aug 19, 2016

Torres, Celgene partner for psoriasis campaign
Amanda Rupp | Jun 1, 2016

World MS Day research to increase independence of MS patients
Amanda Rupp | May 16, 2016

Acute myeloid leukemia persists as major health problem
Amanda Rupp | Apr 14, 2016

WHO calls for better accessibility to psoriasis treatments

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval